Culture

Culture ยท Biography

1927โ€“2004

John R. Vane

With his research group, Vane developed cascade-superfusion bioassay methods for observing the release and fate of biologically active substances.

United Kingdom Tardebigg, United Kingdom Updated 7 November 2026
John R Vane in the photograph identified by the exact source record.
In this biography

Quick facts

Born
1927
Died
2004
Birthplace
Tardebigg, United Kingdom
Nationality
Not independently established
Known for
Prostaglandin research and the mechanism of action of aspirin-like drugs

Why this life matters

Neither achievement is adequately described as the invention of aspirin itself.

Timeline

Key moments

  1. Birth

    Born in Tardebigg, United Kingdom.

  2. Nobel recognition

    Received the Nobel Prize in Physiology or Medicine.

Learning through biological measurement

John Vane was born in Tardebigg, Worcestershire, in 1927. His Nobel autobiography describes a childhood enthusiasm for chemistry and an education interrupted by wartime evacuation and bombing. His later pharmacological training placed biological assay at the centre of experimental work. Rather than treating an instrument's chemical measurement as the only route to knowledge, he used responsive tissues to detect active substances and follow what happened to them in an experimental system.

Sources for this section: [2] ยท [3] ยท [1]

Connecting aspirin with a biochemical pathway

With his research group, Vane developed cascade-superfusion bioassay methods for observing the release and fate of biologically active substances. Work on prostaglandins led in 1971 to evidence that aspirin-like drugs inhibited their biosynthesis. His Nobel lecture places the finding alongside simultaneous studies by other investigators and distinguishes it from the many enzyme effects observed only at high drug concentrations. A plausible explanation required a connection between the biochemical effect and the known physiological actions, not just any inhibition measurable in a tube.

Sources for this section: [2] ยท [3]

Research across institutional boundaries

Vane moved to Wellcome in 1973, taking colleagues who helped develop its prostaglandin research. His autobiography describes prostacyclin work there under Salvador Moncada's leadership. He shared the 1982 medicine prize with Sune Bergstrรถm and Bengt Samuelsson and died in 2004. His contribution joins a method and a mechanism: sensitive biological measurement made unstable mediators accessible, while the aspirin work linked an established drug class with a particular biosynthetic pathway. Neither achievement is adequately described as the invention of aspirin itself.

Sources for this section: [2] ยท [1] ยท [3]

Quick answers

Frequently asked questions about John R. Vane

What is John R. Vane known for?
Prostaglandin research and the mechanism of action of aspirin-like drugs.

Keep exploring

Lives connected to this story

Sources and further reading

Explore the evidence

These references support the biography and offer further reading. Official records, first-person accounts and independent reporting provide different perspectives; image records document attribution and licensing.

  1. 1. Nobel Prize OutreachJohn R. Vane โ€” Facts

    Source scope: Birth/death and award metadata; short official work summary.

  2. 2. Nobel FoundationJohn R. Vane โ€” Biographical

    Source scope: Selected historical passages, as recorded in the research evidence ledger; not a full-document reading claim.

  3. 3. Nobel FoundationJohn R. Vane โ€” Nobel lecture

    Source scope: Selected historical passages, as recorded in the research evidence ledger; not a full-document reading claim.

Back to top โ†‘